(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on ...
AstraZeneca has seen its fair value per share revised upward from $140.96 to $144.38. This change reflects growing analyst ...
TipRanks on MSN
AstraZeneca (AZN) Wins Vote to List Directly in New York — Here’s What It Means for Investors
British pharmaceutical giant AstraZeneca ($AZN) is one step closer to its strategic shift towards the U.S., its largest ...
AstraZeneca said work on its new plant north of Charlottesville will begin immediately and be open within five years.
AstraZeneca was among the first multinational pharmaceutical firms to invest deeply in China's healthcare sector. Through ...
GlobalData on MSN
Health Canada grants NOC for AstraZeneca’s breast cancer therapy
The decision by the Canadian regulator is supported by the findings from the Phase III DESTINY-Breast06 study.
The chief scientific officer of AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference ...
WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...
Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...
Five hundred jobs will be coming to Rockingham County after Merck announced a $3 billion expansion to build a pharmaceutical facility.
AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...
AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results